Who Just Raised

Monocacy Therapeutics Inc.

Monrovia, MD ยท Biotechnology

Monocacy Therapeutics Inc. is a biotechnology company based in Monrovia, Maryland. In a Form D filed with the SEC on October 7, 2026, it reported raising $25,000 from 1 investor as part of an offering of up to $25,000. The first sale in the offering took place on September 25, 2026.

Amount raised
$25,000
Offering size
$25,000
Investors so far
1
First sale
September 25, 2026
Securities offered
Other
Exemption claimed
Rule 506(b)
Industry
Biotechnology
Headquarters
Monrovia, Maryland
Incorporated
Delaware, 2025
Entity type
Corporation

Filings

FiledFormRaisedOffering sizeInvestorsSource
D (new notice) $25,000 $25,000 1 SEC filing
D (new notice) $49 $49 1 SEC filing
D (new notice) $150,000 $150,000 1 SEC filing
D (new notice) $125,000 $125,000 5 SEC filing
D/A (amendment) $114,450 Indefinite 2 SEC filing

Figures come from the company's own filings with the SEC and are shown as reported. How to read a Form D.

Other health care raises in Maryland

Company Location Sector Raised Target Filed
ColoWatch, Inc. /MD/ Gaithersburg, MD Health Care $975K $3M
Templar Nova, Inc. Rockville, MD Health Care $7M $7M
Seraxis Holdings, Inc. Germantown, MD Health Care $10M $10M
Aromha, Inc. Potomac, MD Health Care $75K $75K
Uvantis Therapeutics, Inc. Columbia, MD Health Care $100K $5M
Functional Longevity Labs, Inc. Easton, MD Health Care $25K $1M